Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Author
Tripathi, R.Archibald, L.K.
Mazmudar, R.S.
Conic, R.R.Z.
Rothermel, L.D.
Scott, J.F.
Bordeaux, J.S.
Date
2020Journal
Journal of the American Academy of DermatologyPublisher
Mosby Inc.Type
Article
Metadata
Show full item recordAbstract
Background: Longer time from diagnosis to definitive surgery (TTDS) is associated with increased melanoma-specific mortality. Although black patients present with later-stage melanoma and have worse survival than non-Hispanic white patients, the association between race and TTDS is unknown. Objective: To investigate racial differences in time to melanoma treatment. Methods: Retrospective review of the National Cancer Database (2004-2015). Multivariable logistic regression was used to evaluate the association of race with TTDS, controlling for sociodemographic/disease characteristics. Results: Of the 233,982 patients with melanoma identified, 1221 (0.52%) were black. Black patients had longer TTDS for stage I to III melanoma (P < .001) and time to immunotherapy (P = .01), but not for TTDS for stage IV melanoma or time to chemotherapy (P >. 05 for both). When sociodemographic characteristics were controlled for, black patients had over twice the odds of having a TTDS between 41 and 60 days, over 3 times the odds of having a TTDS between 61 and 90 days, and over 5 times the odds of having a TTDS over 90 days. Racial differences in TTDS persisted within each insurance type. Patients with Medicaid had the longest TTDS (mean, 60.4 days), and those with private insurance had the shortest TTDS (mean, 44.6 days; P < .001 for both). Conclusions: Targeted approaches to improve TTDS for black patients are integral in reducing racial disparities in melanoma outcomes.Keyword
blackchemotherapy
disparities
immunotherapy
insurance
melanoma
mortality
National Cancer Database
non-Hispanic white
racial
stage
survival
time to definitive surgery
time to treatment
Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087781736&doi=10.1016%2fj.jaad.2020.03.094&partnerID=40&md5=1f4f33fad59f3cea3a673c86f56dc542; http://hdl.handle.net/10713/13388ae974a485f413a2113503eed53cd6c53
10.1016/j.jaad.2020.03.094
Scopus Count
Collections
Related articles
- Racial/Ethnic Disparities Associated With Initial Hemodialysis Access.
- Authors: Zarkowsky DS, Arhuidese IJ, Hicks CW, Canner JK, Qazi U, Obeid T, Schneider E, Abularrage CJ, Freischlag JA, Malas MB
- Issue date: 2015 Jun
- The Impact of the Affordable Care Act on Disparities in Private and Medicaid Insurance Coverage Among Patients Under 65 With Newly Diagnosed Cancer.
- Authors: Agarwal A, Katz AJ, Chen RC
- Issue date: 2019 Sep 1
- The ongoing racial disparities in melanoma: An analysis of the Surveillance, Epidemiology, and End Results database (1975-2016).
- Authors: Qian Y, Johannet P, Sawyers A, Yu J, Osman I, Zhong J
- Issue date: 2021 Jun
- The Odds of Stage IV Melanoma Diagnoses Based on Socioeconomic Factors.
- Authors: Dick M, Aurit S, Silberstein P
- Issue date: 2019 Jul/Aug
- Delays in Diagnosis and Treatment of Breast Cancer: A Safety-Net Population Profile.
- Authors: Jaiswal K, Hull M, Furniss AL, Doyle R, Gayou N, Bayliss E
- Issue date: 2018 Dec